{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T23:35:36Z","timestamp":1791416136719,"version":"4.3.3"},"reference-count":52,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.nmd.2016.03.003","type":"journal-article","created":{"date-parts":[[2016,3,28]],"date-time":"2016-03-28T12:37:03Z","timestamp":1459168623000},"page":"337-341","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Myasthenia gravis and amyotrophic lateral sclerosis: A pathogenic overlap"],"prefix":"10.1016","volume":"26","author":[{"given":"H\u00e5vard Torvik","family":"Gotaas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geir Olve","family":"Skeie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nils Erik","family":"Gilhus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nmd.2016.03.003_bib0010","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S1474-4422(15)00145-3","article-title":"Myasthenia gravis: subgroup classification and therapeutic strategies","volume":"14","author":"Gilhus","year":"2015","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.nmd.2016.03.003_bib0015","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1016\/S0140-6736(00)05186-2","article-title":"Myasthenia gravis","volume":"357","author":"Vincent","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.nmd.2016.03.003_bib0020","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/mus.22006","article-title":"Anti-MuSK antibody myasthenia gravis: clinical findings and response to treatment in two large cohorts","volume":"44","author":"Guptill","year":"2011","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2016.03.003_bib0025","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.cell.2008.10.002","article-title":"Lrp4 is a receptor for Agrin and forms a complex with MuSK","volume":"135","author":"Kim","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.nmd.2016.03.003_bib0030","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.neuron.2008.10.006","article-title":"LRP4 serves as a coreceptor of agrin","volume":"60","author":"Zhang","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.nmd.2016.03.003_bib0035","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1212\/WNL.0b013e3181ad53c2","article-title":"Seropositive myasthenia gravis: a nationwide epidemiologic study","volume":"73","author":"Heldal","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2016.03.003_bib0040","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1600-0404.1984.tb00825.x","article-title":"Epidemiology of myasthenia gravis in Norway","volume":"70","author":"Storm-Mathisen","year":"1984","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.nmd.2016.03.003_bib0045","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1111\/j.1468-1331.2010.03019.x","article-title":"Guidelines for treatment of autoimmune neuromuscular transmission disorders","volume":"17","author":"Skeie","year":"2010","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.nmd.2016.03.003_bib0050","first-page":"847393","article-title":"Myasthenia gravis: a review of available treatment approaches","volume":"2011","author":"Gilhus","year":"2011","journal-title":"Autoimmune Dis"},{"key":"10.1016\/j.nmd.2016.03.003_bib0055","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1136\/jnnp.2009.188151","article-title":"Motor neuron disease: the bare essentials","volume":"9","author":"Talbot","year":"2009","journal-title":"Pract Neurol"},{"key":"10.1016\/j.nmd.2016.03.003_bib0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/17482960802585469","article-title":"Genetic studies of amyotrophic lateral sclerosis: controversies and perspectives","volume":"10","author":"Beleza-Meireles","year":"2009","journal-title":"Amyotroph Lateral Scler"},{"key":"10.1016\/j.nmd.2016.03.003_bib0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jns.2009.09.029","article-title":"The evidence for altered RNA metabolism in amyotrophic lateral sclerosis (ALS)","volume":"288","author":"Strong","year":"2010","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.nmd.2016.03.003_bib0070","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.mcn.2012.06.001","article-title":"Mitochondria and ALS: implications from novel genes and pathways","volume":"55","author":"Cozzolino","year":"2013","journal-title":"Mol Cell Neurosci"},{"key":"10.1016\/j.nmd.2016.03.003_bib0075","doi-asserted-by":"crossref","first-page":"166","DOI":"10.3109\/17482968.2011.641569","article-title":"Endoplasmic reticulum stress and the ER mitochondrial calcium cycle in amyotrophic lateral sclerosis","volume":"13","author":"Lautenschlaeger","year":"2012","journal-title":"Amyotroph Lateral Scler"},{"key":"10.1016\/j.nmd.2016.03.003_bib0080","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1093\/jnen\/63.9.964","article-title":"Activated microglia initiate motor neuron injury by a nitric oxide and glutamate-mediated mechanism","volume":"63","author":"Zhao","year":"2004","journal-title":"J Neuropathol Exp Neurol"},{"issue":"2","key":"10.1016\/j.nmd.2016.03.003_bib0085","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/wsbm.1187","article-title":"The role of regulatory T cells in neurodegenerative diseases","volume":"5","author":"He","year":"2013","journal-title":"Wiley Interdiscip Rev Syst Biol Med"},{"key":"10.1016\/j.nmd.2016.03.003_bib0090","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S1474-4422(11)70015-1","article-title":"Neuroinflammation in amyotrophic lateral sclerosis: role of glial activation in motor neuron disease","volume":"10","author":"Philips","year":"2011","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.nmd.2016.03.003_bib0095","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jneuroim.2004.10.009","article-title":"Evidence for systemic immune system alterations in sporadic amyotrophic lateral sclerosis (sALS)","volume":"159","author":"Zhang","year":"2005","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.nmd.2016.03.003_bib0100","doi-asserted-by":"crossref","first-page":"312","DOI":"10.2169\/internalmedicine.36.312","article-title":"Amyotrophic lateral sclerosis with anti-acetylcholine receptor antibody","volume":"36","author":"Okuyama","year":"1997","journal-title":"Intern Med"},{"key":"10.1016\/j.nmd.2016.03.003_bib0105","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/CND.0b013e31824db163","article-title":"Amyotrophic lateral sclerosis with positive anti-acetylcholine receptor antibodies. Case report and review of the literature","volume":"14","author":"Mehanna","year":"2012","journal-title":"J Clin Neuromuscul Dis"},{"key":"10.1016\/j.nmd.2016.03.003_bib0110","doi-asserted-by":"crossref","first-page":"477","DOI":"10.3109\/17482968.2012.711836","article-title":"Unusual occurrence of amyotrophic lateral sclerosis in myasthenia gravis","volume":"13","author":"Naik","year":"2012","journal-title":"Amyotroph Lateral Scler"},{"key":"10.1016\/j.nmd.2016.03.003_bib0115","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.clineuro.2007.08.022","article-title":"Amyotrophic lateral sclerosis patients and ocular ptosis","volume":"110","author":"Pinto","year":"2008","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.nmd.2016.03.003_bib0120","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1002\/mus.21653","article-title":"Eliminating false-positive results in serum tests for neuromuscular autoimmunity","volume":"41","author":"Apiwattanakul","year":"2010","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2016.03.003_bib0125","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1001\/archneur.1986.00520030026007","article-title":"Amyotrophic lateral sclerosis. Associated clinical disorders and immunological evaluations","volume":"43","author":"Appel","year":"1986","journal-title":"Arch Neurol"},{"key":"10.1016\/j.nmd.2016.03.003_bib0130","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1177\/1352458511427719","article-title":"Multiple sclerosis and amyotrophic lateral sclerosis: is there a link?","volume":"18","author":"Etemadifar","year":"2012","journal-title":"Mult Scler"},{"key":"10.1016\/j.nmd.2016.03.003_bib0135","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1212\/WNL.0b013e3182a6cc13","article-title":"Autoimmune disease preceding amyotrophic lateral sclerosis: an epidemiologic study","volume":"81","author":"Turner","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2016.03.003_bib0140","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/intimm\/dxu099","article-title":"Disease origin and progression in amyotrophic lateral sclerosis: an immunology perspective","volume":"27","author":"Malaspina","year":"2015","journal-title":"Int Immunol"},{"key":"10.1016\/j.nmd.2016.03.003_bib0145","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s10048-008-0164-y","article-title":"Familial risks for amyotrophic lateral sclerosis and autoimmune diseases","volume":"10","author":"Hemminki","year":"2009","journal-title":"Neurogenetics"},{"key":"10.1016\/j.nmd.2016.03.003_bib0150","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1159\/000329523","article-title":"Incidence and clinical features of amyotrophic lateral sclerosis in More and Romsdal county, Norway","volume":"37","author":"Gundersen","year":"2011","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.nmd.2016.03.003_bib0155","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1159\/000110384","article-title":"Prognostic factors and survival in amyotrophic lateral sclerosis","volume":"13","author":"Tysnes","year":"1994","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.nmd.2016.03.003_bib0160","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1212\/WNL.55.9.1262","article-title":"Increasing mortality from amyotrophic lateral sclerosis in Norway?","volume":"55","author":"Seljeseth","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2016.03.003_bib0165","doi-asserted-by":"crossref","first-page":"520","DOI":"10.3109\/21678421.2015.1051991","article-title":"Epidemiology of amyotrophic lateral sclerosis in Minnesota: a year-long population based study","volume":"16","author":"Harper","year":"2015","journal-title":"Am Lat Scler Frontotemp Degen"},{"key":"10.1016\/j.nmd.2016.03.003_bib0170","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/CND.0b013e31824db163","article-title":"Amyotrophic lateral sclerosis with positive anti-acetylcholine receptor antibodies: case report and review of the literature","volume":"14","author":"Mehanna","year":"2012","journal-title":"J Clin Neuromuscul Dis"},{"key":"10.1016\/j.nmd.2016.03.003_bib0175","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1080\/146608200300079536","article-title":"El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis","volume":"1","author":"Brooks","year":"2000","journal-title":"Amyotroph Lateral Scler Other Motor Neuron Disord"},{"key":"10.1016\/j.nmd.2016.03.003_bib0180","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/(SICI)1097-4598(199805)21:5<577::AID-MUS3>3.0.CO;2-5","article-title":"Diagnostic difficulties in myasthenia gravis","volume":"21","author":"Maher","year":"1998","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2016.03.003_bib0185","doi-asserted-by":"crossref","first-page":"380","DOI":"10.3109\/08916930903518073","article-title":"The auto-antigen repertoire in myasthenia gravis","volume":"43","author":"Vrolix","year":"2010","journal-title":"Autoimmunity"},{"key":"10.1016\/j.nmd.2016.03.003_bib0190","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1111\/ene.12632","article-title":"Association between diabetes and amyotrophic lateral sclerosis in Sweden","volume":"22","author":"Mariosa","year":"2015","journal-title":"Eur J Neurol"},{"issue":"Suppl. 1","key":"10.1016\/j.nmd.2016.03.003_bib0195","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1080\/167-146608201300079382","article-title":"Are there immunologically treatable motor neuron diseases?","volume":"2","author":"Nobile-Orazio","year":"2001","journal-title":"Amyotroph Lateral Scler Other Motor Neuron Disord"},{"issue":"Suppl.","key":"10.1016\/j.nmd.2016.03.003_bib0200","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/0022-510X(94)90188-0","article-title":"Treatment of ALS with high dose pulse cyclophosphamide","volume":"124","author":"Smith","year":"1994","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.nmd.2016.03.003_bib0205","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1600-0404.1990.tb01602.x","article-title":"Immunosuppressive treatment of patients with amyotrophic lateral sclerosis","volume":"82","author":"Werdelin","year":"1990","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.nmd.2016.03.003_bib0210","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/BF02444000","article-title":"Intravenous immunoglobulin therapy in amyotrophic lateral sclerosis","volume":"243","author":"Meucci","year":"1996","journal-title":"J Neurol"},{"key":"10.1016\/j.nmd.2016.03.003_bib0215","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1006\/nbdi.2002.0487","article-title":"Minocycline slows disease progression in a mouse model of amyotrophic lateral sclerosis","volume":"10","author":"Kriz","year":"2002","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.nmd.2016.03.003_bib0220","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.expneurol.2010.12.010","article-title":"Treatment with minocycline after disease onset alters astrocyte reactivity and increases microgliosis in SOD1 mutant mice","volume":"228","author":"Keller","year":"2011","journal-title":"Exp Neurol"},{"key":"10.1016\/j.nmd.2016.03.003_bib0225","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/acn3.26","article-title":"LRP4 antibodies in serum and CSF from amyotrophic lateral sclerosis patients","volume":"1","author":"Tzartos","year":"2014","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.nmd.2016.03.003_bib0230","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1136\/jnnp.36.2.244","article-title":"Neurogenic muscle involvement in myasthenia gravis. A clinical and histopathological study","volume":"36","author":"Oosterhuis","year":"1973","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.nmd.2016.03.003_bib0235","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/j.jocn.2011.01.010","article-title":"Muscle atrophy in muscle-specific tyrosine kinase (MuSK)-related myasthenia gravis","volume":"18","author":"Moon","year":"2011","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.nmd.2016.03.003_bib0240","doi-asserted-by":"crossref","first-page":"252","DOI":"10.3389\/fnins.2014.00252","article-title":"ALS as a distal axonopathy: molecular mechanisms affecting neuromuscular junction stability in the presymptomatic stages of the disease","volume":"8","author":"Moloney","year":"2014","journal-title":"Front Neurosci"},{"key":"10.1016\/j.nmd.2016.03.003_bib0245","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.expneurol.2003.10.004","article-title":"Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man","volume":"185","author":"Fischer","year":"2004","journal-title":"Exp Neurol"},{"key":"10.1016\/j.nmd.2016.03.003_bib0250","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.coph.2009.03.007","article-title":"Neuromuscular junction destruction during amyotrophic lateral sclerosis: insights from transgenic models","volume":"9","author":"Dupuis","year":"2009","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.nmd.2016.03.003_bib0255","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1007\/s12031-010-9467-1","article-title":"The \u201cdying-back\u201d phenomenon of motor neurons in ALS","volume":"43","author":"Dadon-Nachum","year":"2011","journal-title":"J Mol Neurosci"},{"key":"10.1016\/j.nmd.2016.03.003_bib0260","doi-asserted-by":"crossref","first-page":"e44148","DOI":"10.1371\/journal.pone.0044148","article-title":"Fatigue and muscle atrophy in a mouse model of myasthenia gravis is paralleled by loss of sarcolemmal nNOS","volume":"7","author":"Meinen","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.nmd.2016.03.003_bib0265","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jns.2010.03.022","article-title":"Neuronal NOS is dislocated during muscle atrophy in amyotrophic lateral sclerosis","volume":"294","author":"Suzuki","year":"2010","journal-title":"J Neurol Sci"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896615301024?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896615301024?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:04:39Z","timestamp":1760774679000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896615301024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":52,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S0960896615301024"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2016.03.003","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Myasthenia gravis and amyotrophic lateral sclerosis: A pathogenic overlap","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2016.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}